Original language | English (US) |
---|---|
Pages (from-to) | 2-9 |
Number of pages | 8 |
Journal | Life sciences |
Volume | 159 |
DOIs | |
State | Published - Aug 15 2016 |
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics(all)
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Life sciences, Vol. 159, 15.08.2016, p. 2-9.
Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - The Fourteenth International Conference on Endothelin (ET-14), Savannah, U.S.A.
AU - Pollock, David M.
AU - Gulati, Anil
AU - Ergul, Adviye
N1 - Funding Information: Image 25 Rita C. Tostes, PhD, is currently a Professor at the School of Medicine of Ribeirao Preto, University of São Paulo, a researcher at the National Council for Scientific and Technological Development (CNPq) and a member of the Foundation for Research Support of the State of São Paulo (FAPESP). She holds the degrees of B.Sc. in Pharmacy, University of São Paulo, M.Sc. and PhD in Biological Sciences (Pharmacology, School of Medicine of Ribeirao Preto, University of São Paulo). She served as an intern and post-doctoral fellow at the Albert Einstein College of Medicine. NY, University of Montreal, Clinical Research Institute of Montreal and the Medical College of Georgia (now a part of Augusta University). Her research interests have focused on vascular signaling pathways and include work in angiotensin and endothelin mechanisms. Her work includes the potential role of glycosylation with N-acetylglucosamine (O-GlcNAc) in vascular (dys)function. Importantly, Dr. Tostes has also been a leading figure in the area of sex differences in vascular function. Funding Information: Image 28 David J. Webb, MD, DSc, FRCP, FRSE, FMedSci, is Professor of Therapeutics and Clinical Pharmacology in the BHF Centre of Research Excellence at the University of Edinburgh, where he established its Centre for Cardiovascular Science, and consultant physician at the Royal Infirmary of Edinburgh. He is recognized internationally for his work on endothelial function and arterial stiffness, much of which focuses on the endothelin system, and on the investigation and effective treatment of patients with complex hypertension and chronic kidney disease. His work is mainly translational and he provides leadership to two new UK clinical PhD training initiatives in translational medicine and therapeutics (TMAT) based in Scotland, funded by the Wellcome Trust and Medical Research Council. He is a Fellow of the Royal Society of Edinburgh and UK Academy of Medical Sciences, and was awarded the SKB Silver and Lilly Gold Medals from the British Pharmacological Society for his research and for contributions to pharmacology, respectively. Dr. Webb Dr. Webb is a member of the International Advisory Board of the endothelin conference program. Funding Information: Image 17 Janet Maguire, PhD, is a Senior Research Associate in the Clinical Pharmacology Unit, University of Cambridge and a Fellow of Queens' College, Cambridge. She is a member of the BHF Receptor Research Group whose focus is the pharmacology of established and novel G-protein coupled receptors in the human cardiovascular system and who have particular expertise in the endothelin peptides and their receptors. Dr. Maguire has been a leading authority on the unique aspects of endothelin receptor pharmacology and structure-function studies. Her research also includes study of the chemokine GPCR CCR5 as an important component of HIV-related vascular complications. Dr. Maguire is currently supported by the British Heart Foundation and has been a Wellcome Trust/MRC 4-year PhD program Principal Investigator and a member of the International Union of Pharmacology Receptor Nomenclature Sub-Committee on Endothelin Receptors. Copyright: Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2016/8/15
Y1 - 2016/8/15
UR - http://www.scopus.com/inward/record.url?scp=84982094957&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84982094957&partnerID=8YFLogxK
U2 - 10.1016/j.lfs.2016.06.015
DO - 10.1016/j.lfs.2016.06.015
M3 - Editorial
C2 - 27321090
AN - SCOPUS:84982094957
SN - 0024-3205
VL - 159
SP - 2
EP - 9
JO - Life sciences
JF - Life sciences
ER -